Elucidata Corporation is a TechBio company based in Cambridge, MA that specializes in transforming drug discovery through the integration of various forms of biomedical data. Their biomedical data platform, Polly, offers a range of features including data harmonization, data quality assessment, and the ability to curate and manage data as per specific research needs. Elucidata provides custom solutions for target identification, meta-analysis, biomarker discovery, signature exploration, patient stratification, bioinformatics pipeline development, and machine learning model deployment. Their platform caters to bioinformaticians, biologists, data custodians, and research teams, offering tools and services to enhance data analysis and visualization.
With a commitment to building the future of drug discovery, Elucidata aims to leverage technology and data to unlock new frontiers in the field. They offer resources such as blogs, case studies, webinars, and white papers to provide industry insights and customer stories. Elucidata's mission is to revolutionize drug discovery by integrating diverse biomedical data sources and empowering researchers with advanced tools and solutions.
Generated from the website